Published in Psychopharmacology (Berl) on February 19, 2011
Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review. Clin Psychopharmacol Neurosci (2012) 0.89
Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice. Schizophr Bull (2013) 0.81
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications. Pharmacogenomics (2011) 0.79
Histamine receptor signaling in energy homeostasis. Neuropharmacology (2015) 0.76
Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment. PLoS One (2014) 0.76
Genome-wide methylation profiling of schizophrenia. Balkan J Med Genet (2015) 0.75
Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Can J Psychiatry (2016) 0.75
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry (2016) 0.75
A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 59.30
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med (2005) 28.99
A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet (2003) 26.59
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered (2002) 8.64
Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry (1999) 8.04
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs (2005) 5.84
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov (2004) 4.31
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology (2003) 3.35
A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab (2006) 2.82
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry (2005) 2.35
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics (2005) 1.97
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry (2007) 1.93
Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry (2004) 1.83
Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry (2000) 1.67
Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry (1999) 1.53
Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. Pharmacol Ther (2009) 1.48
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res (2003) 1.47
Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry (2004) 1.39
Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet (2005) 1.32
Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res (2009) 1.26
Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes (2004) 1.25
Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol (2005) 1.11
Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population. J Nerv Ment Dis (2005) 1.02
Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes (2001) 1.01
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet (2005) 0.97
Atypical antipsychotics and glucose homeostasis. J Clin Psychiatry (2005) 0.97
Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry (2001) 0.96
Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatr Serv (2004) 0.96
Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A (2001) 0.96
Metabolic findings from the CATIE trial and their relation to tolerability. CNS Spectr (2006) 0.96
Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry (2003) 0.93
Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet (2005) 0.92
The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol (2007) 0.92
Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Methods Find Exp Clin Pharmacol (2005) 0.90
CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes (2006) 0.90
HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. J Clin Psychopharmacol (2009) 0.89
Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br J Psychiatry (2008) 0.87
Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res (1988) 0.87
Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.85
The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J (2006) 0.84
Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol (2009) 0.84
Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study. Pharmacogenomics J (2010) 0.84
Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment. Eur Neuropsychopharmacol (2005) 0.83
Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol (2007) 0.83
Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment. Psychiatr Genet (2002) 0.82
Alternative promoter use and splice variation in the human histamine H1 receptor gene. Am J Respir Cell Mol Biol (2006) 0.81
Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design. Am J Health Syst Pharm (2006) 0.79
Hypothalamic neuronal histamine modulates adaptive behavior and thermogenesis in response to endogenous pyrogen. Obes Res (1995) 0.77
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry (2013) 5.19
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial. Lancet (2007) 4.01
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation (2006) 3.26
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care (2006) 2.87
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Reinstitutionalisation in mental health care: comparison of data on service provision from six European countries. BMJ (2004) 2.81
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Mental health care institutions in nine European countries, 2002 to 2006. Psychiatr Serv (2008) 2.76
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry (2011) 2.75
Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry (2008) 2.35
Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet (2012) 2.29
Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet (2002) 2.26
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med (2010) 2.24
Structured patient-clinician communication and 1-year outcome in community mental healthcare: cluster randomised controlled trial. Br J Psychiatry (2007) 2.15
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis. J Clin Psychopharmacol (2013) 2.07
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.90
Handedness correlates with the dominant Parkinson side: a systematic review and meta-analysis. Mov Disord (2011) 1.84
Smart sensors to network the world. Sci Am (2004) 1.77
A longitudinal study of blood pressure variability in African-American and European American youth. J Hypertens (2010) 1.76
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet (2010) 1.67
The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res (2006) 1.66
Ataxia rating scales are age-dependent in healthy children. Dev Med Child Neurol (2014) 1.58
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis. Eur Respir J (2013) 1.58
Genetic influence on early age-related maculopathy: a twin study. Ophthalmology (2002) 1.57
Genetic influences on daytime and night-time blood pressure: similarities and differences. J Hypertens (2009) 1.57
Effectively working on rehabilitation goals: 24-month outcome of a randomized controlled trial of the Boston psychiatric rehabilitation approach. Can J Psychiatry (2011) 1.51
A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics (2013) 1.51
Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res (2002) 1.50
Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr (2010) 1.50
Life stressors as mediators of the relation between socioeconomic position and mental health problems in early adolescence: the TRAILS study. J Am Acad Child Adolesc Psychiatry (2009) 1.48
Genetic and environmental determinants of lipid profile in black and white youth: a study of four candidate genes. Ethn Dis (2005) 1.47
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines. Pharmacoeconomics (2008) 1.46
Moderators of blood pressure development from childhood to adulthood: a 10-year longitudinal study. J Pediatr (2002) 1.45
Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. Br J Psychiatry (2008) 1.43
Genetic epidemiological approaches in the study of risk factors for cardiovascular disease. Eur J Epidemiol (2004) 1.40
FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and African-American youth. BMC Med Genet (2010) 1.38
Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability. J Clin Psychopharmacol (2013) 1.38
A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems. BMC Psychiatry (2009) 1.36
Ethnic differences in resting heart rate variability: a systematic review and meta-analysis. Psychosom Med (2015) 1.31
The SH2B gene is associated with serum leptin and body fat in normal female twins. Obesity (Silver Spring) (2007) 1.30
Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet (2012) 1.29
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One (2009) 1.28
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc Natl Acad Sci U S A (2014) 1.28
The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol (2010) 1.28
Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet (2013) 1.27
Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain (2011) 1.27
The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support. Schizophr Bull (2008) 1.27
Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet (2011) 1.26
Heritability of QT interval: how much is explained by genes for resting heart rate? J Cardiovasc Electrophysiol (2007) 1.25
Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) (2002) 1.24
High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2010) 1.23
Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr Bull (2012) 1.22
The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One (2012) 1.19
Effects of epileptiform EEG discharges on cognitive function: is the concept of "transient cognitive impairment" still valid? Epilepsy Behav (2004) 1.19
The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res (2006) 1.18
Study protocol for the development of a European measure of best practice for people with long term mental health problems in institutional care (DEMoBinc). BMC Psychiatry (2009) 1.17
Ethnic differences and heritability of heart rate variability in African- and European American youth. Am J Cardiol (2005) 1.16
Bivariate genetic modeling of cardiovascular stress reactivity: does stress uncover genetic variance? Psychosom Med (2007) 1.16
The Georgia Cardiovascular Twin Study: influence of genetic predisposition and chronic stress on risk for cardiovascular disease and type 2 diabetes. Twin Res Hum Genet (2006) 1.16
The development of the Quality Indicator for Rehabilitative Care (QuIRC): a measure of best practice for facilities for people with longer term mental health problems. BMC Psychiatry (2011) 1.16
Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr Res (2003) 1.15
Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol (2012) 1.15
Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophr Res (2009) 1.13
Cognitive behaviour therapy to prevent complicated grief among relatives and spouses bereaved by suicide: cluster randomised controlled trial. BMJ (2007) 1.13
Cardiovascular characteristics in American youth with prehypertension. Am J Hypertens (2007) 1.12
Gompertz' survivorship law as an intrinsic principle of aging. Med Hypotheses (2012) 1.11
Clinical recovery in first-episode psychosis. Schizophr Bull (2008) 1.11
Growth of left ventricular mass in African American and European American youth. Hypertension (2002) 1.11
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Mental disorders among persons with heart disease - results from World Mental Health surveys. Gen Hosp Psychiatry (2007) 1.10
Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet (2008) 1.09
A longitudinal study in youth of heart rate variability at rest and in response to stress. Int J Psychophysiol (2009) 1.08
Phenoconversion of cytochrome P450 2D6: the need for identifying the intermediate metabolizer genotype. J Clin Psychiatry (2013) 1.08
A Dutch guideline for the use of clozapine. Aust N Z J Psychiatry (2010) 1.08
Heritability and stability of resting blood pressure. Twin Res Hum Genet (2005) 1.07
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry (2007) 1.07
UMOD as a susceptibility gene for end-stage renal disease. BMC Med Genet (2012) 1.06